Literature DB >> 18573086

Structure-based view of epidermal growth factor receptor regulation.

Kathryn M Ferguson1.   

Abstract

High-resolution X-ray crystal structures determined in the past six years dramatically influence our view of ligand-induced activation of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. Ligand binding to the extracellular region of EGFR promotes a major domain reorganization, plus local conformational changes, that are required to generate an entirely receptor-mediated dimer. In this activated complex the intracellular kinase domains associate to form an asymmetric dimer that supports the allosteric activation of one kinase. These models are discussed with emphasis on recent studies that add details or bolster the generality of this view of activation of this family of receptors. The EGFR family is implicated in several disease states, perhaps most notably in cancers. Activating tumor mutations have been identified in the intracellular and extracellular regions of EGFR. The impact of these tumor mutations on the understanding of EGFR activation and of its inhibition is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573086      PMCID: PMC2745238          DOI: 10.1146/annurev.biophys.37.032807.125829

Source DB:  PubMed          Journal:  Annu Rev Biophys        ISSN: 1936-122X            Impact factor:   12.981


  74 in total

Review 1.  ErbB receptors: from oncogenes to targeted cancer therapies.

Authors:  Hongtao Zhang; Alan Berezov; Qiang Wang; Geng Zhang; Jeffrey Drebin; Ramachandran Murali; Mark I Greene
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.

Authors:  Samuel Bouyain; Patti A Longo; Shiqing Li; Kathryn M Ferguson; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

3.  An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.

Authors:  Stuart McLaughlin; Steven O Smith; Michael J Hayman; Diana Murray
Journal:  J Gen Physiol       Date:  2005-06-13       Impact factor: 4.086

Review 4.  ERBB receptors and cancer: the complexity of targeted inhibitors.

Authors:  Nancy E Hynes; Heidi A Lane
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

Review 5.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

6.  Conformational changes accompany phosphorylation of the epidermal growth factor receptor C-terminal domain.

Authors:  Nam Y Lee; John G Koland
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

7.  Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib.

Authors:  Eunice L Kwak; Raffaella Sordella; Daphne W Bell; Nadia Godin-Heymann; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; David R Driscoll; Panos Fidias; Thomas J Lynch; Sridhar K Rabindran; John P McGinnis; Allan Wissner; Sreenath V Sharma; Kurt J Isselbacher; Jeffrey Settleman; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

8.  Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.

Authors:  Jessica P Dawson; Mitchell B Berger; Chun-Chi Lin; Joseph Schlessinger; Mark A Lemmon; Kathryn M Ferguson
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Ligand-induced structural transitions in ErbB receptor extracellular domains.

Authors:  Jessica P Dawson; Zimei Bu; Mark A Lemmon
Journal:  Structure       Date:  2007-08       Impact factor: 5.006

10.  Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Authors:  Jeffrey C Lee; Igor Vivanco; Rameen Beroukhim; Julie H Y Huang; Whei L Feng; Ralph M DeBiasi; Koji Yoshimoto; Jennifer C King; Phioanh Nghiemphu; Yuki Yuza; Qing Xu; Heidi Greulich; Roman K Thomas; J Guillermo Paez; Timothy C Peck; David J Linhart; Karen A Glatt; Gad Getz; Robert Onofrio; Liuda Ziaugra; Ross L Levine; Stacey Gabriel; Tomohiro Kawaguchi; Keith O'Neill; Haumith Khan; Linda M Liau; Stanley F Nelson; P Nagesh Rao; Paul Mischel; Russell O Pieper; Tim Cloughesy; Daniel J Leahy; William R Sellers; Charles L Sawyers; Matthew Meyerson; Ingo K Mellinghoff
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

View more
  126 in total

1.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

2.  Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.

Authors:  Sashikanth Banappagari; Miriam Corti; Seth Pincus; Seetharama Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2012-06-26

3.  Structural basis for negative cooperativity in growth factor binding to an EGF receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

4.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

5.  Protein flexibility: coordinate uncertainties and interpretation of structural differences.

Authors:  Alexander A Rashin; Abraham H L Rashin; Robert L Jernigan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-10-22

6.  Two-photon 3D FIONA of individual quantum dots in an aqueous environment.

Authors:  Ruobing Zhang; Eli Rothenberg; Gilbert Fruhwirth; Paul D Simonson; Fangfu Ye; Ido Golding; Tony Ng; Ward Lopes; Paul R Selvin
Journal:  Nano Lett       Date:  2011-09-13       Impact factor: 11.189

7.  Structure-activity relationship of conformationally constrained peptidomimetics for antiproliferative activity in HER2-overexpressing breast cancer cell lines.

Authors:  Sashikanth Banappagari; Sharon Ronald; Seetharama D Satyanarayanajois
Journal:  Medchemcomm       Date:  2011-01-01       Impact factor: 3.597

Review 8.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 9.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

10.  Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors.

Authors:  Abedelnasser Abulrob; Zhengfang Lu; Ewa Baumann; Dusan Vobornik; Rod Taylor; Danica Stanimirovic; Linda J Johnston
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.